BONEZONE Magazine | OMTEC Expo的动态

Orthopedic M&A?deals accelerated in 2023, according to ORTHOWORLD Inc. reporting. The jump?in activity marks the first year-over-year increase since 2020, but still fell short of the 42 orthopedic transactions ORTHOWORLD tracked that year. Still, there’s reason for optimism and a livelier M&A market in the years ahead. Interest in orthopedic M&A remains strong and a few major players have with recent acquisitions: Smith & Nephew acquired CartiHeal last November to capture the company’s novel technology for regenerating cartilage in the knee. Enovis acquired Lima Corporate?in January to gain addition tractions in the extremities and reconstruction segments. Stryker acquired France-based SERF in December to add to its hip replacement portfolio across Europe. Globus Medical became the second biggest player in spine — the most active M&A segment in orthopedics — when it?completed its merger?with NuVasive last September. restor3d acquired Conformis - acquired by restor3d?last year with the goal of scaling Conformis’ portfolio of personalized orthopedic devices. ORTHOWORLD expects?M&A deal volume?to hold steady in 2024 amid the higher input costs for buyers and the relative scarcity of commercial-ready companies. However, the market could become more active sometime in 2025 as interest in orthopedic targets remains strong. Read the article here: https://lnkd.in/eUS5ik8C #MedicalDevices #Innovation #Acquisition

A recent article from ORTHOWORLD Inc. highlights the surge in mergers and acquisitions focused on #digital assets in the orthopedic space. Companies are increasingly recognizing the value of integrating digital technologies into their offerings. As per the article, transactions for technology assets account for ????% ???? ?????? ?????????? ???????? ???? ?????? ?????? ???? ??????????????????. As we move forward as an industry, integrating digital solutions will help ?????????? ????????????????????, ?????????????? ????????????????????????, ???????????????????? ????????????????????, ?????? ?????????????? ?????????????? ????????. At Enhatch, we’re proud to be part of this evolution, offering digital 3D planning solutions that streamline the preoperative planning process for patient-specific solutions. We can help medical device companies, distributors, and point-of-care facilities ???????????? ?????????? ?????? ???????????????? ???? ??????????????-???????????????? ??????????????????. #3Dplanning #medtech #preoperativeplanning #orthopedics #meddev #PointOfCare #distributors https://lnkd.in/e9m4n-G8

ORTHOWORLD Inc. expects?M&A deal volume?to hold steady this year amid the higher input costs for buyers and the relative scarcity of commercial-ready companies. However, the market is due for a rebound and could become more active sometime in 2025 as interest in #orthopedic targets remains strong. Check out our latest infographic sponsored by Intech for recent deals that are worth monitoring and a breakdown of the most active players in orthopedics in recent years: https://lnkd.in/eUw_EFUk #orthopedicsurgery #medtech #MandA #marketintelligence

Last month, the Elos Orthopedics team from the US went on a week-long expedition in collaboration with our colleagues at Klingel across Germany and Switzerland - Precisely, Rosenheim, H?lstein, and Matzingen. It was a week of fruitful discussions on how our recent merger will translate into tangible benefits to the orthopedic industry. Here's a glimpse into their experience, as recounted by Tim Turner, VP of Sales and Business Development at our Memphis site: ? "We met a strong team, primed for expansion," Tim reflects. "Each facility exuded capability, with established processes and systems in place, and untapped potential waiting to be unleashed. It's exciting to see the convergence of our visions and values through collaboration, and beyond the metrics, there's a sense of kinship and collective ambition." he adds. ? Throughout the week, conversations revolved around the nuances of collaboration and integration. "We delved into how we can harmonize our efforts," Tim explains. "It's not only about working together; it's about leveraging our respective strengths to propel us forward." ? The integration of Elos Medtech and Klingel operations in orthopedic production paints a compelling picture. "Our processes seamlessly complement each other," Tim notes. "Through integration we're paving the way for holistic solutions that cater to the entire orthopedic manufacturing supply chain." ? This collaboration means more than just operational streamlining; it signifies a strategic repositioning in the market. "With Klingel, we're not just broadening our horizons," Tim stresses. "We're reshaping our collective identity, transitioning from two entities into a unified powerhouse”. Find out more about Elos Orthopedics: https://lnkd.in/ej5WDCZY #ElosMedtech #Klingel #Orthopedics #MedicalDevices #CDMO #ContractManufacturing #Integration

It has been a slow year for M&A but some of the most acquisitive companies are starting to ramp up activity. Enabling technology is the busiest segment among the top 10 companies for orthopedic M&A, accounting for 26% of their transactions since 2016. Our latest chart of the month ranks companies by number of acquisitions. It includes top-tier players and a few smaller companies. #mergersandacquisitions #orthopedics

Since Orthofix's merger with SeaSpine in January 2023, most of the attention has been placed on the company's #spine and #orthobiologics business. New President & CEO Massimo Calafiore also sees an opportunity for the company's trauma and enabling technology portfolios. Our Chart of the Month looks at Orthofix's trauma sales from the last eight years. Just over a quarter of its trauma sales came from the U.S. in 2023. "What we see in front of us is an enormous opportunity in the United States, where we have a very small market share," Calafiore said. "So, there is a lot of focused investment that we are making right now in that market, not just around the marketing and sales, but also innovation." https://lnkd.in/dR9PGRha #orthopedics #fracturerepair #earningsseason

BTIG analysts summed up Stryker's Q3 report pretty well in their report headline: "Stryker simply executes." Mako surgical robot installations continue to drive sales demand for the company's #orthopedic and #surgical devices. Find out more about Stryker's Q3 performance on MassDevice. #medtech #meddevice

Acting Locally - Serving Globally As a trusted specialized partner, we leverage our capabilities in the U.S., Europe and China, offering Complete Performance? and vertical integration to leading orthopedic companies worldwide. Our deep expertise, combined with our product development and manufacturing service offerings, forms comprehensive supply chain management solutions for customers globally. But we go further - Recognizing the increasing demand in our industry for global suppliers with also a strong local presence, we have designed a "glocal" approach. In today’s dynamic business landscape, this approach is crucial. It enables us to ensure a secure and reliable global supply chain for our customers around the world. From design insights to delivery logistics, Elos Medtech serves as a full-service partner, adapting our capabilities to complement your own. We understand that you seek more than just a manufacturer for your products; you need solutions that translate into cost savings and increased efficiency for your business. Discover more: https://lnkd.in/ej5WDCZY #ElosMedtech #Orthopedics #MedicalDevices #CDMO #ContractManufacturing #SupplyChain

HERE ARE A FEW OF MY BIASES ABOUT THE ORTHOPEDIC INDUSTRY?? ??The best way to acquire #orthopedic devices is through a truly independent rep acting in your best interest, not in the company's best interest. ??The best way to sell and distribute #orthopaedic devices is by having the ability to represent multiple companies and not being bound by geography or non-competes. ??Non-competes are used to scare and manipulate reps into putting a company's wants over their surgeon customers' wants and needs. (I am skeptical non-competes are going away) ??Companies would be better served if they had the surgeons' and patients' best interests in mind and not their shareholders. ??Smaller Ortho companies have products that are just as good as Big Orthos products. ??Limited vendor contracts are not the best way for facilities to reduce spending on devices. What are some of your biases?

Big Ortho vs Small Ortho? ?? Not exactly… There are pros and cons to every situation. ? The prospects of working for a large orthopedic company aren’t all bad, but they’re certainly not all good either. ? Likewise, partnering with smaller companies can offer tremendous upside, but there can be challenges. ——————————————————————— Whichever perspective you're coming from, it's a conversation worth having. That's why #linkedin is so valuable. An ongoing dialogue about things that matter. Let's keep the conversation moving forward. #medicaldevicesales #orthopedics #ascdx